Does staged-Volume Radiosurgery of Large Arteriovenous Malformations improve Outcome by Reducing the Rate of Adverse Radiation Effects?
Obliteration and hemorrhage rates of large AVMs treated by SVRS are similar to historical SSRS. However, SVRS offers a lower rate of AREs.
The Hydroxymethylglutaryl coenzyme A reductase inhibitor SIM prevents the activation of ERK in SHR to mediate regression of myocardial hypertrophy in SHR.